Prescriber Profiling
- Alexander C. Tsai, MD, PhD
- From the University of Washington School of Medicine, Seattle, WA 98104-2499.
TO THE EDITOR:
Given that fewer than 1% of American Medical Association (AMA) members have participated in the Prescribing Data Restriction Program (PDRP), only 25% of surveyed members are aware of the program's existence, and 66% disapprove of the sale of physician-specific prescribing data to drug companies, Grande's concern that “the AMA opt-out program is not an effective way to address the concerns of physicians and their patients” (1) is a tactful understatement.
A thorough literature review at the PDRP's inception would have …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
